Last reviewed · How we verify

NCT04329468

Detachable String MCE for Upper Gastrointestinal Tract and Small Bowel

Status unknown NA Last updated 21 July 2020
What this trial tests

NA trial testing DS-MCE in Capsule Endoscopy in 25 participants. Status unknown.

Timeline
10 March 2020
Primary endpoint
20 August 2020
20 September 2020

Quick facts

Lead sponsorZhuan Liao
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment25
Start date10 March 2020
Primary completion20 August 2020
Estimated completion20 September 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhuan Liao

Who can join

Adults 18 to 80, any sex, with Capsule Endoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the feasibility and safety of DS-MCE with a novel way for complete examination in UGI tract and small bowel, compared with EGD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A novel capsule endoscopy for upper and mid-GI tract: the UMGI capsule.
    Jiang B, Qian YY, Wang YC, Pan J, et al · · 2023 · cited 6× · PMID 36927462 · DOI 10.1186/s12876-023-02696-5

Verify or expand the search:

Other trials of DS-MCE

Trials testing the same drug.

Other recruiting trials for Capsule Endoscopy

Currently open trials in the same condition.

Other Zhuan Liao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04329468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing